Fight CRC Clinical Trial Finder
| NCT ID | Title | 阶段 | Date Added | 地点 | Prior IO Allowed | CRC-directed | Status | 药物 | 标签 |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT06066424 |
TitlePhase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) | 阶段
第 1 阶段
|
Date Added 2023-10-04 |
地点
Texas, United States
|
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
招聘
|
药物
Cyclophosphamide, Fludarabine Phosphate, Rimiducid, TROP2-CAR-NK Cells |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06185556 |
TitleCOLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases | 阶段
第二阶段
|
Date Added 2023-12-29 |
地点
荷兰
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06218914 |
TitleA Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation | 阶段
第 1 阶段
|
Date Added 2024-01-23 |
地点
California, United States
Kansas, United States Missouri, United States New York, United States Pennsylvania, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States |
Prior IO Allowed 是 |
CRC-directed 是 |
Status
活跃，非招募
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT04853017 |
TitleELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201) | 阶段
第 1 阶段
|
Date Added 2021-04-21 |
地点
California, United States
Colorado, United States Iowa, United States Massachusetts, United States Missouri, United States New York, United States Tennessee, United States Texas, United States |
Prior IO Allowed 是 |
CRC-directed 是 |
Status
活跃，非招募
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03990233 |
Title晚期实体瘤患者BI 765063单药治疗及与BI 754091联合治疗试验 | 阶段
第 1 阶段
|
Date Added 2019-06-18 |
地点
比利时
法国 |
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
BI 754091, BI 765063 |
标签
MSS/ MMRp
|
| NCT ID NCT03412877 |
Title对转移性癌症患者施用经基因工程改造可表达对新抗原有反应的 T 细胞受体的自体 T 细胞 | 阶段
第二阶段
|
Date Added 2018-01-29 |
地点
Maryland, United States
|
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
招聘
|
药物
Aldesleukin, Cyclophosphamide, Fludarabine, Individual Patient TCR-Transduced PBL, Pembrolizumab (Keytruda) |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03530397 |
Title在晚期实体瘤受试者中评估 MEDI5752 的研究 | 阶段
第 1 阶段
|
Date Added 2018-05-21 |
地点
Michigan, United States
New York, United States North Carolina, United States Rhode Island, United States Tennessee, United States Virginia, United States 澳大利亚 法国 意大利 大韩民国 荷兰 葡萄牙 西班牙 台湾 |
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
Carboplatin, MEDI5752, Pembrolizumab, Pemetrexed, Alimta, Imfinzi, Keytruda, Paraplatin |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03985891 |
TitleJS001 联合化疗对局部晚期结肠癌患者的疗效 | 阶段
第 1 阶段/第 2 阶段
|
Date Added 2019-06-14 |
地点
中国
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
招聘
|
药物
Anti-PD-1 Monoclonal Antibody JS001, Chemotherapy |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03783403 |
TitleA Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers | 阶段
第 1 阶段
|
Date Added 2018-12-21 |
地点
Alabama, United States
Arizona, United States California, United States Colorado, United States Missouri, United States New York, United States North Carolina, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Tennessee, United States Texas, United States 澳大利亚 加拿大 法国 意大利 大韩民国 西班牙 英国 |
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
CC-95251, cetuximab, Rituximab |
标签
MSS/ MMRp
|
| NCT ID NCT01061515 |
TitleBiweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer | 阶段
第 1 阶段
|
Date Added 2010-02-03 |
地点
Missouri, United States
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
活跃，非招募
|
药物
Bevacizumab, capecitabine, Intraperitoneal Oxaliplatin, Avastin, Eloxatin, Xeloda |
标签
MSS/ MMRp
|
